Image Credit: Edugrafo / Shutterstock In a recent comprehensive network meta-analysis published in the journal Translational Psychiatry , researchers evaluated the safety and effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for individuals with mental illness and comorbid obesity or overweight-related metabolic risk
As a cardiovascular translational researcher working with genetics engineering approaches, I find this direction highly exciting because integrating real-world evidence with molecular and omics-based insights could significantly advance precision cardiometabolic medicine
On the other hand, cold weather can freeze your pens
Those on tirzepatide lowered their A1c by 2-2.3 percentage points (depending on injection dose) compared to those on semaglutide who achieved a reduction of 1.86 percentage points (with 1 mg weekly injections)
and ELI LILLY AND COMPANY In August 2024, Cecily King, through her attorneys, filed a lawsuit against Novo Nordisk and Eli Lilly after suffering severe personal injuries related to her use of Ozempic and Trulicity
